Wolfe Research reaffirmed its ‘Outperform’ rating on UnitedHealth Group but cut its price target to $330 from $363, citing ongoing medical billing pressures. The firm highlighted that UnitedHealth’s ...

Johnson & Johnson (NYSE:JNJ) is one of Goldman Sachs’ top healthcare stock picks. On July 10, analysts at Wolfe Research ...

Cedar and Rowan, the two newest wolf pups at Ely’s International Wolf Center, are stars of science in two research studies before they’re integrated into the center’s wolf pack that’s on display.

Fintel reports that on July 14, 2025, Wolfe Research downgraded their outlook for HF Sinclair (NYSE:DINO) from Peer Perform ...

Tepfer, published in the Cambridge Archaeological Journal, explores the transformation of elk rock art in the Mongolian Altai ...

Centene Corporation (NYSE:CNC) is one of the 10 Best Growth Stocks to Buy With Huge Upside Potential. On July 2, Wolfe ...

Overall, Wolfe favors a mix of growth and value as the second half of 2025 begins. Related articles Wolfe Research refreshes high-conviction ideas heading into H2 ...

Wolfe Research bumped its price target on Samsara (NYSE: IOT) to $45 from $41 in early June, keeping its Outperform rating in place.

The research firm reiterated the company’s solid position amid the “TTR craze” while also echoing its commercial execution strategy. Wolfe Research Initiates Coverage of BridgeBio Pharma ...

Fintel reports that on May 13, 2025, Wolfe Research upgraded their outlook for Insulet (BMV:PODD) from Peer Perform to Outperform.

Fastenal (NASDAQ:FAST) on Thursday was upgraded to Peer Perform from a previous investment rating of Underperform by analysts at Wolfe Research. They said the industrial distributor appears well ...

Wolfe Research released a report discussing key investment themes for 2025, highlighting a stronger U.S. dollar and predicting a decline in long-term interest rates. The firm attributed the rise ...